Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CM027550-010
Application #
3610158
Study Section
Project Start
1982-04-16
Project End
1985-07-01
Budget Start
1985-07-01
Budget End
1985-07-01
Support Year
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of Texas MD Anderson Cancer Center
Department
Type
Hospitals
DUNS #
001910777
City
Houston
State
TX
Country
United States
Zip Code
77030
Raber, M N; Adams, F; Kavanagh, J et al. (1987) Phase I trial of caracemide using bolus and infusion schedules. Cancer Treat Rep 71:349-52
Spitzer, G; Valdivieso, M; Farha, P et al. (1986) I.v. melphalan in carcinoma of the lung: effect of cyclophosphamide priming on hematopoietic toxicity. Cancer Treat Rep 70:449-53
Ajani, J A; Dimery, I; Chawla, S P et al. (1986) Phase II studies of homoharringtonine in patients with advanced malignant melanoma;sarcoma;and head and neck, breast, and colorectal carcinomas. Cancer Treat Rep 70:375-9
Kavanagh, J J; Stringer, C A; Copeland, L J et al. (1986) Phase II trial of fludarabine in patients with epithelial ovarian cancer. Cancer Treat Rep 70:425-6
Legha, S S; Tenney, D M; Krakoff, I R (1986) Phase I study of taxol using a 5-day intermittent schedule. J Clin Oncol 4:762-6
Chiuten, D F; Umsawasdi, T; Dhingra, H M et al. (1985) Phase II clinical trial of diaziquone in bronchogenic carcinoma. Cancer Treat Rep 69:921-2